Comprehensive Analysis of Tumour Sub-Volumes for Radiomic Risk Modelling in Locally Advanced HNSCC

Imaging features for radiomic analyses are commonly calculated from the entire gross tumour volume (GTV <sub>entire</sub><inline-formula>)</inline-formula>. However, tumours are biologically complex and the consideration of different tumour regions in radiomic models may lead...

Full description

Bibliographic Details
Main Authors: Stefan Leger, Alex Zwanenburg, Karoline Leger, Fabian Lohaus, Annett Linge, Andreas Schreiber, Goda Kalinauskaite, Inge Tinhofer, Nika Guberina, Maja Guberina, Panagiotis Balermpas, Jens von der Grün, Ute Ganswindt, Claus Belka, Jan C. Peeken, Stephanie E. Combs, Simon Boeke, Daniel Zips, Christian Richter, Mechthild Krause, Michael Baumann, Esther G.C. Troost, Steffen Löck
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/12/10/3047
id doaj-04ceb70c3f4c40f3b3e0bcf9c2cf0b4e
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Stefan Leger
Alex Zwanenburg
Karoline Leger
Fabian Lohaus
Annett Linge
Andreas Schreiber
Goda Kalinauskaite
Inge Tinhofer
Nika Guberina
Maja Guberina
Panagiotis Balermpas
Jens von der Grün
Ute Ganswindt
Claus Belka
Jan C. Peeken
Stephanie E. Combs
Simon Boeke
Daniel Zips
Christian Richter
Mechthild Krause
Michael Baumann
Esther G.C. Troost
Steffen Löck
spellingShingle Stefan Leger
Alex Zwanenburg
Karoline Leger
Fabian Lohaus
Annett Linge
Andreas Schreiber
Goda Kalinauskaite
Inge Tinhofer
Nika Guberina
Maja Guberina
Panagiotis Balermpas
Jens von der Grün
Ute Ganswindt
Claus Belka
Jan C. Peeken
Stephanie E. Combs
Simon Boeke
Daniel Zips
Christian Richter
Mechthild Krause
Michael Baumann
Esther G.C. Troost
Steffen Löck
Comprehensive Analysis of Tumour Sub-Volumes for Radiomic Risk Modelling in Locally Advanced HNSCC
Cancers
radiomic
image-based risk modelling
machine learning
personalised therapy
radiation oncology
author_facet Stefan Leger
Alex Zwanenburg
Karoline Leger
Fabian Lohaus
Annett Linge
Andreas Schreiber
Goda Kalinauskaite
Inge Tinhofer
Nika Guberina
Maja Guberina
Panagiotis Balermpas
Jens von der Grün
Ute Ganswindt
Claus Belka
Jan C. Peeken
Stephanie E. Combs
Simon Boeke
Daniel Zips
Christian Richter
Mechthild Krause
Michael Baumann
Esther G.C. Troost
Steffen Löck
author_sort Stefan Leger
title Comprehensive Analysis of Tumour Sub-Volumes for Radiomic Risk Modelling in Locally Advanced HNSCC
title_short Comprehensive Analysis of Tumour Sub-Volumes for Radiomic Risk Modelling in Locally Advanced HNSCC
title_full Comprehensive Analysis of Tumour Sub-Volumes for Radiomic Risk Modelling in Locally Advanced HNSCC
title_fullStr Comprehensive Analysis of Tumour Sub-Volumes for Radiomic Risk Modelling in Locally Advanced HNSCC
title_full_unstemmed Comprehensive Analysis of Tumour Sub-Volumes for Radiomic Risk Modelling in Locally Advanced HNSCC
title_sort comprehensive analysis of tumour sub-volumes for radiomic risk modelling in locally advanced hnscc
publisher MDPI AG
series Cancers
issn 2072-6694
publishDate 2020-10-01
description Imaging features for radiomic analyses are commonly calculated from the entire gross tumour volume (GTV <sub>entire</sub><inline-formula>)</inline-formula>. However, tumours are biologically complex and the consideration of different tumour regions in radiomic models may lead to an improved outcome prediction. Therefore, we investigated the prognostic value of radiomic analyses based on different tumour sub-volumes using computed tomography imaging of patients with locally advanced head and neck squamous cell carcinoma. The GTV <sub>entire</sub> was cropped by different margins to define the rim and the corresponding core sub-volumes of the tumour. Subsequently, the best performing tumour rim sub-volume was extended into surrounding tissue with different margins. Radiomic risk models were developed and validated using a retrospective cohort consisting of 291 patients in one of the six Partner Sites of the German Cancer Consortium Radiation Oncology Group treated between 2005 and 2013. The validation concordance index (C-index) averaged over all applied learning algorithms and feature selection methods using the GTV<inline-formula><math display="inline"><semantics><msub><mrow></mrow><mo form="prefix">entire</mo></msub></semantics></math></inline-formula> achieved a moderate prognostic performance for loco-regional tumour control (C-index: 0.61 ± 0.04 (mean ± std)). The models based on the 5 mm tumour rim and on the 3 mm extended rim sub-volume showed higher median performances (C-index: 0.65 ± 0.02 and 0.64 ± 0.05, respectively), while models based on the corresponding tumour core volumes performed less (C-index: 0.59 ± 0.01). The difference in C-index between the 5 mm tumour rim and the corresponding core volume showed a statistical trend (<i>p</i> = 0.10). After additional prospective validation, the consideration of tumour sub-volumes may be a promising way to improve prognostic radiomic risk models.
topic radiomic
image-based risk modelling
machine learning
personalised therapy
radiation oncology
url https://www.mdpi.com/2072-6694/12/10/3047
work_keys_str_mv AT stefanleger comprehensiveanalysisoftumoursubvolumesforradiomicriskmodellinginlocallyadvancedhnscc
AT alexzwanenburg comprehensiveanalysisoftumoursubvolumesforradiomicriskmodellinginlocallyadvancedhnscc
AT karolineleger comprehensiveanalysisoftumoursubvolumesforradiomicriskmodellinginlocallyadvancedhnscc
AT fabianlohaus comprehensiveanalysisoftumoursubvolumesforradiomicriskmodellinginlocallyadvancedhnscc
AT annettlinge comprehensiveanalysisoftumoursubvolumesforradiomicriskmodellinginlocallyadvancedhnscc
AT andreasschreiber comprehensiveanalysisoftumoursubvolumesforradiomicriskmodellinginlocallyadvancedhnscc
AT godakalinauskaite comprehensiveanalysisoftumoursubvolumesforradiomicriskmodellinginlocallyadvancedhnscc
AT ingetinhofer comprehensiveanalysisoftumoursubvolumesforradiomicriskmodellinginlocallyadvancedhnscc
AT nikaguberina comprehensiveanalysisoftumoursubvolumesforradiomicriskmodellinginlocallyadvancedhnscc
AT majaguberina comprehensiveanalysisoftumoursubvolumesforradiomicriskmodellinginlocallyadvancedhnscc
AT panagiotisbalermpas comprehensiveanalysisoftumoursubvolumesforradiomicriskmodellinginlocallyadvancedhnscc
AT jensvondergrun comprehensiveanalysisoftumoursubvolumesforradiomicriskmodellinginlocallyadvancedhnscc
AT uteganswindt comprehensiveanalysisoftumoursubvolumesforradiomicriskmodellinginlocallyadvancedhnscc
AT clausbelka comprehensiveanalysisoftumoursubvolumesforradiomicriskmodellinginlocallyadvancedhnscc
AT jancpeeken comprehensiveanalysisoftumoursubvolumesforradiomicriskmodellinginlocallyadvancedhnscc
AT stephanieecombs comprehensiveanalysisoftumoursubvolumesforradiomicriskmodellinginlocallyadvancedhnscc
AT simonboeke comprehensiveanalysisoftumoursubvolumesforradiomicriskmodellinginlocallyadvancedhnscc
AT danielzips comprehensiveanalysisoftumoursubvolumesforradiomicriskmodellinginlocallyadvancedhnscc
AT christianrichter comprehensiveanalysisoftumoursubvolumesforradiomicriskmodellinginlocallyadvancedhnscc
AT mechthildkrause comprehensiveanalysisoftumoursubvolumesforradiomicriskmodellinginlocallyadvancedhnscc
AT michaelbaumann comprehensiveanalysisoftumoursubvolumesforradiomicriskmodellinginlocallyadvancedhnscc
AT esthergctroost comprehensiveanalysisoftumoursubvolumesforradiomicriskmodellinginlocallyadvancedhnscc
AT steffenlock comprehensiveanalysisoftumoursubvolumesforradiomicriskmodellinginlocallyadvancedhnscc
_version_ 1724517885732192256
spelling doaj-04ceb70c3f4c40f3b3e0bcf9c2cf0b4e2020-11-25T03:43:51ZengMDPI AGCancers2072-66942020-10-01123047304710.3390/cancers12103047Comprehensive Analysis of Tumour Sub-Volumes for Radiomic Risk Modelling in Locally Advanced HNSCCStefan Leger0Alex Zwanenburg1Karoline Leger2Fabian Lohaus3Annett Linge4Andreas Schreiber5Goda Kalinauskaite6Inge Tinhofer7Nika Guberina8Maja Guberina9Panagiotis Balermpas10Jens von der Grün11Ute Ganswindt12Claus Belka13Jan C. Peeken14Stephanie E. Combs15Simon Boeke16Daniel Zips17Christian Richter18Mechthild Krause19Michael Baumann20Esther G.C. Troost21Steffen Löck22OncoRay—National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden—Rossendorf, 01307 Dresden, GermanyOncoRay—National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden—Rossendorf, 01307 Dresden, GermanyOncoRay—National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden—Rossendorf, 01307 Dresden, GermanyOncoRay—National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden—Rossendorf, 01307 Dresden, GermanyOncoRay—National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden—Rossendorf, 01307 Dresden, GermanyDepartment of Radiotherapy, Hospital Dresden-Friedrichstadt, 01067 Dresden, GermanyGerman Cancer Research Center (DKFZ), Heidelberg and German Cancer Consortium (DKTK) Partner Site, 10117 Berlin, GermanyGerman Cancer Research Center (DKFZ), Heidelberg and German Cancer Consortium (DKTK) Partner Site, 10117 Berlin, GermanyGerman Cancer Research Center (DKFZ), Heidelberg and German Cancer Consortium (DKTK) Partner Site, 45147 Essen, GermanyGerman Cancer Research Center (DKFZ), Heidelberg and German Cancer Consortium (DKTK) Partner Site, 45147 Essen, GermanyGerman Cancer Research Center (DKFZ), Heidelberg and German Cancer Consortium (DKTK) Partner Site, 60596 Frankfurt, GermanyGerman Cancer Research Center (DKFZ), Heidelberg and German Cancer Consortium (DKTK) Partner Site, 60596 Frankfurt, GermanyGerman Cancer Research Center (DKFZ), Heidelberg and German Cancer Consortium (DKTK) Partner Site, 81377 Munich, GermanyGerman Cancer Research Center (DKFZ), Heidelberg and German Cancer Consortium (DKTK) Partner Site, 81377 Munich, GermanyGerman Cancer Research Center (DKFZ), Heidelberg and German Cancer Consortium (DKTK) Partner Site, 81377 Munich, GermanyGerman Cancer Research Center (DKFZ), Heidelberg and German Cancer Consortium (DKTK) Partner Site, 81377 Munich, GermanyGerman Cancer Research Center (DKFZ), Heidelberg and German Cancer Consortium (DKTK) Partner Site, 72076 Tübingen, GermanyGerman Cancer Research Center (DKFZ), Heidelberg and German Cancer Consortium (DKTK) Partner Site, 72076 Tübingen, GermanyOncoRay—National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden—Rossendorf, 01307 Dresden, GermanyOncoRay—National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden—Rossendorf, 01307 Dresden, GermanyOncoRay—National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden—Rossendorf, 01307 Dresden, GermanyOncoRay—National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden—Rossendorf, 01307 Dresden, GermanyOncoRay—National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden—Rossendorf, 01307 Dresden, GermanyImaging features for radiomic analyses are commonly calculated from the entire gross tumour volume (GTV <sub>entire</sub><inline-formula>)</inline-formula>. However, tumours are biologically complex and the consideration of different tumour regions in radiomic models may lead to an improved outcome prediction. Therefore, we investigated the prognostic value of radiomic analyses based on different tumour sub-volumes using computed tomography imaging of patients with locally advanced head and neck squamous cell carcinoma. The GTV <sub>entire</sub> was cropped by different margins to define the rim and the corresponding core sub-volumes of the tumour. Subsequently, the best performing tumour rim sub-volume was extended into surrounding tissue with different margins. Radiomic risk models were developed and validated using a retrospective cohort consisting of 291 patients in one of the six Partner Sites of the German Cancer Consortium Radiation Oncology Group treated between 2005 and 2013. The validation concordance index (C-index) averaged over all applied learning algorithms and feature selection methods using the GTV<inline-formula><math display="inline"><semantics><msub><mrow></mrow><mo form="prefix">entire</mo></msub></semantics></math></inline-formula> achieved a moderate prognostic performance for loco-regional tumour control (C-index: 0.61 ± 0.04 (mean ± std)). The models based on the 5 mm tumour rim and on the 3 mm extended rim sub-volume showed higher median performances (C-index: 0.65 ± 0.02 and 0.64 ± 0.05, respectively), while models based on the corresponding tumour core volumes performed less (C-index: 0.59 ± 0.01). The difference in C-index between the 5 mm tumour rim and the corresponding core volume showed a statistical trend (<i>p</i> = 0.10). After additional prospective validation, the consideration of tumour sub-volumes may be a promising way to improve prognostic radiomic risk models.https://www.mdpi.com/2072-6694/12/10/3047radiomicimage-based risk modellingmachine learningpersonalised therapyradiation oncology